va semaglutide criteria for use Weight management medications chronic in 37 veterans affairs medical centers—A medication use evaluation - Walczuk - 2024 - Obesity Science & Practice Wegovy VA Coverage Pathway: How

May cause temporary fatigue or mild flu-like symptoms in some users

Extracellular GS-Es are degraded sequentially by cell surface enzymes, -glutamyl transpeptidase (GGT) and dipeptidases, to cysteinyl-electrophile conjugates that are N-acetylated to mercapturic acid in the kidneys

Rely on marketing blends without functional dosing

For patients requiring long-term PPI therapy, the American Gastroenterological Association recommends using the lowest effective dose for maintenance therapy

Too many peptide stacks involve compounds that hit similar pathways and end up creating diminishing returns or amplified side effects